FRANKLIN LAKES, N.J., Jan. 20, 2022 /PRNewswire/ — BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that a study conducted in collaboration with the European Molecular Biology Laboratory (EMBL) and published as the cover story of the January 21st issue of the journal, Science, profiles a new BD... Read more
RYE BROOK, N.Y.–(BUSINESS WIRE)–Jan. 20, 2022– Global water technology company, Xylem (NYSE:XYL), announced today that almost 80 percent of its 16,000 employees volunteered their time to help solve urgent water challenges in 2021. Xylem’s global team collectively donated 113,000 hours in their communities, across 55 countries. The commitment of volunteer hours doubled from 2020 to... Read more
GE Healthcare enters into a comprehensive 10-year partnership with Circle Health Group, covering Circle’s national network of hospitals in the UK Partnership to empower Circle’s clinicians through cutting-edge technology and more impactful use of data Will help ensure better outcomes for NHS patients as well as Circle’s private patients London, UK – January 20 2022... Read more
[Delayed] Corporate Governance Report | IR News | News Release ＆ IR News | Investor Relations Read more
Prolab precision pumps, autosamplers and nano-flow to cap-LC UHPLC systems to further enhance performance and robustness of timsTOF 4D proteomics and metabolomics solutions Unique Zirconium™ nano-LC to cap-LC pump technology for 4 nL/min to 10 μL/min flow rates with split-less UHPLC operation for optimized proteomics results Innovative, proprietary Zirconium Cube™ autosampler with mobile injection unit... Read more
PreOmics Announces Closing of Series B Financing to Accelerate Research, Development and Commercialization of Proteomics Tools and Consumables PreOmics Offers Unique Technologies, Advanced Automation Solutions and High-Performance Consumables for the Homogenization, Enrichment and Sample Preparation of Biopsy, Tissue, Cell Line and Plasma Samples in Unbiased, Deep Proteomics for Biopharma and Clinical Rese MUNICH, Germany –... Read more
Circulating tumor cells (CTCs) are cells that have broken away from a primary tumor and entered the circulatory system. They can initiate new tumors (metastases) that are the driving factor for the vast majority of cancer-related deaths. Biopharma researchers, cancer researchers and oncologists have focused on the detection and analyses of CTCs to monitor drug... Read more
MENLO PARK, Calif., Jan. 14, 2022 (GLOBE NEWSWIRE) — PacBio (NASDAQ: PACB), a leading provider of high-quality, highly accurate sequencing platforms, today announced that the Compensation Committee of the Company’s Board of Directors granted non-qualified stock options covering an aggregate of 80,000 shares of PacBio common stock, and restricted stock units (“RSUs”) covering 40,000 shares... Read more
RYE BROOK, N.Y.–(BUSINESS WIRE)–Jan. 13, 2022– Xylem Inc. (NYSE: XYL), a leading global water technology company dedicated to solving the world’s most challenging water issues, will release its fourth quarter 2021 results at 6:55 a.m. (ET) on Thursday, February 3, 2022. At 10:00 a.m. (ET), Xylem’s senior management team will host a conference call with... Read more
MENLO PARK, Calif., Jan. 13, 2022 (GLOBE NEWSWIRE) — PacBio (Nasdaq: PACB), a leading developer of high-quality, highly accurate, sequencing platforms, welcomes Lara Toerien, Ph.D., as Vice President and General Manager for the company’s Americas region. Lara will be responsible for leading and developing PacBio’s commercial organization within North and South America while furthering its... Read more